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ABSTRACT 
WRAPS – A SYSTEM FOR DETERMINING THE PROBABILITY OF 
PROKARYOTIC PROTEIN ANNOTATION CORRECTNESS 
 
Benjamin K. Nelson, MS 
 
University of Nebraska, 2012 
 
Advisor: Dhundy Bastola, Ph.D 
 
 Advances in sequencing technology have resulted in the sequencing of whole 
genomes from many simple organisms such as fungi and bacteria, while allowing the 
assembly of much more complex genomes like humans and chimpanzees. Consequently, 
association of segments of newly sequenced genomes to specific function (i.e. 
annotation) is being completed by comparative study of protein coding regions from 
previously annotated genome data.  While this is an ideal procedure to process and 
annotate huge number of available genomic sequences, this approach can potentially lead 
to propagating erroneous annotation in a public sequence repository and vastly diminish 
the integrity of these new annotation of genome sequences.  In this project, the WRongly 
Annotated Protein identification System (WRAPS) has been created to analyze 
previously annotated proteins quickly and efficiently. The likeliness that the protein is 
correctly annotated is determined by weighted scoring schema based on conservation of 
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protein domain, the domains present in different reading frames, and isoelectric point. A 
study of 88,023 proteins of Yersinia, Staphylococcus, and Bacillus using WRAPS show 
that there are several proteins that can be considered wrongly annotated, as well as the 
correctness of annotation among these proteins. 
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INTRODUCTION 
 
In science, the scientific method is used to solve problems.  This method enables a 
scientist to test a property within the natural world.  To do this, information is needed to 
first define a hypothesis and to test that hypothesis itself.  In the fields of proteomics and 
genomics, this method holds true as well.  In these sciences, one of the most common 
information are sequences, both DNA and protein.  Since the discovery of DNA, many 
methods have been developed to sequence DNA and proteins for different organisms.  
Over time, these methods have become quicker and cheaper leading to an exponential 
increase in the number of sequences available.  One of the leading databases, GenBank, 
showed an exponential rise in sequences being added to it, now doubling in size every 18 
months, as seen in Figure 1 [1].  
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Figure 1: Increase in the number of sequences added to GenBank 
 
 While DNA and protein sequences are useful by themselves, often times an 
adjoining annotation is needed.  An annotation tells useful things about the sequence.  A 
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DNA sequence annotation may have information about coding sequences, the protein 
product of these coding sequences, and the protein translation of these coding sequences 
[2].  A protein sequence may have information about particular domains and molecules 
that bind to the protein.  To discover the annotations, the traditional method is to 
experiment with these proteins within a biological lab [2].  While this method is very 
thorough, it is very slow.  With the exponential increase in the number of sequencing 
projects, annotating these sequences using the traditional method is falling more and 
more behind.   
 To solve this problem automated methods were used to keep up with the 
increasing wave of sequence data being introduced.  Systems such as GLIMMER and 
GeneMark help fill in the annotations for the abundance of sequences [3].  These methods 
create new annotations by comparing genes from the sequences to similar previously 
annotated genes already available in the database.  This method is very fast and effective 
in annotating new sequences. However, it has been continuously introducing error to 
databases.  If a gene is incorrectly annotated, then subsequent similar genes will also be 
incorrectly annotated.  As incorrectly annotated genes are used in the annotation process, 
the error propagates.  In fact, the percent of misannotated sequences of new sequences 
submitted to public databases has been rising [4].  This causes a problem with research as 
annotations of proteins must be validated as to avoid erroneous results. 
 To help reverse this problem by identifying the incorrect annotation, the Wrongly 
Annotated Protein Identification System (WRAPS) has been created.  This system tests 
each protein on six different qualities that would be found in most proteins.  Each of 
these evidence tests are weighted for each genus. The resulting weights are used to score 
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individual proteins.  A protein's score will range from zero to one, giving the probability 
that a protein is correctly annotated.  By using these scores, proteins may be flagged as 
incorrectly annotated so that flagged proteins may receive more stringent review and 
possibly be removed from the pool of possible proteins to be used in homology searches.  
Once the incorrectly annotated proteins are identified, the contents of public databases 
can be improved. 
 WRAPS has been created with certain goals in mind.  First and foremost, this 
system is to provide an accurate measure into the correctness of a protein.  Next, this 
system should be fast, as to avoid some of the pitfalls of its predecessor, GARBASE [5].  
Next, this is to take advantage of biological properties of proteins and their corresponding 
nucleotides.  Today, there are methods to identify wrongly annotated genomes.  However, 
most are concerned only with computational aspects surrounding the methods used to 
annotate them [5, 6, 7].  While this may work better in a pipeline, these methods use the 
same set of tools resulting in the incorrect annotation in the first place.  By using 
biological properties of proteins, this allows for new models to be made to further enrich 
protein annotation.  Next, this system should be able to process information quickly, as 
annotation quality control means nothing if it falls victim to the flaws of traditional 
annotation in a wet lab.  This is accomplished by parallelizing the evidence tests upon 
individual proteins.  This greatly improves the amount of time it takes for WRAPS to run.  
This is because of the numbers of protein sequences to be tested within the database, 
which range from 50,000 to 300,000 in different jobs.  Finally, this system should be able 
to be portable across many machines, provided that you have access to a MySQL 
database.  This is accomplished by storing configurations in a file and accepting 
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configurations as command line arguments, so that the programs themselves do not have 
to be changed when using different computers. 
   
BACKGROUND 
 
 
DNA 
 Deoxyribonucleic acid, or better known as DNA, is the basic cellular information 
for living cells.  DNA is comprised of two strands [9].  Each of these strands is a polymer, 
meaning it is a chain of repeated molecules.  This polymer is structured as a series of 
nitrogenous bases attached to a sugar backbone.  While the sugar backbone is a 
constantly repeated pattern, the bases vary.  In fact, there are four different nitrogenous 
bases, namely adenine (A), cytosine (C), guanine (G), and thymine (T) [9].  Together, 
these bases are called nucleotides.  By varying the sequence of these nucleotides, the 
DNA codes for different cellular products.  Between the two strands, each of the 
nucleotides in one strand is matched up with the complement base in the opposite strand.  
For instance, the A nucleotide will match to the T nucleotide in the opposite strand and 
the C nucleotide will match to the G nucleotide in the opposite strand.  The opposite of 
these pairings are also true between the two DNA strands.  While both strands are 
comprised of the same molecules, they are oriented in opposite directions.  One strand is 
called the 5’ to 3’ strand, while the other is called the 3’ to 5’ strand.  This is because of 
the structure of the sugar backbone in DNA.  The sugar takes the form of a ring, and each 
of the carbon atoms can be numbered from one to five.  On the five carbon, there is a 
phosphate group that is attached to it.  This phosphate is also attached to a three carbon 
on the next phosphate group.  Depending on the way that this is read (from left to right), 
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the five carbon will be bonded to the phosphate, which is then bonded to the three carbon 
for a “5 to 3” strand, or the opposite direction for the “3 to 5 strand”.  The chemical 
structure of a DNA strand can be seen in Figure 2.  When studying DNA within 
bioinformatics, DNA is represented by a letter string of A, C, G, and T to designate the 
order of these nitrogenous bases in the 5' to 3' direction.  It is not necessary to have the 
sequence of the 3 to 5 strand, as this can be derived by taking the complement of the 5 to 
3 strand and reversing it.   
 
Figure 2: Chemical structure of DNA [36] 
 
 Within a DNA sequence, there are important subsequences within it are called 
genes.  Genes code for proteins.  Proteins are polymers of discrete subunits called amino 
acids.  Much like DNA, proteins are different, based on the amino acids used in the 
sequence.  To be able to utilize the information within DNA, another molecule is made 
called ribonucleic acid (RNA) [10].  This serves as an intermediate to be taken to the 
ribosomes, which are proteins which facilitate the translation of DNA. RNA is much like 
DNA, only with a few differences.  The first major difference is that RNA is only single 
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stranded, unlike DNA, which is double stranded.  The second major difference is RNA 
has the uracil (U) nucleotide instead of the T nucleotide.  The third major difference is 
RNA uses a different sugar molecule to use as the background.   
 
PROTEIN 
 With each amino acid in a protein sequence, it has a corresponding sequence of 
three contiguous nucleotides.  Each of these 3-mers is called a codon.  Each of these 64 
possible codons code for an amino acid [10,11,12].  Within humans, most bacteria, and 
many other organisms there are 20 different amino acids to be coded for [11,12].  Since 
not all of the possible codons can code for a unique amino acid, this means that most 
amino acids are coded for by multiple codons.  For most amino acids, there are on 
average three different codons that can code for it.  However, there are two amino acids, 
methionine and tryptophan, that have only one way of being coded.  There are also three 
special codons called “stop” codons which terminate translation of the protein. 
 In a DNA sequence, a gene works only when the codons are in the correct frame.  
The frame of a DNA sequence defines which nucleotide 3-mers together form a codon.  
There are six different frames for a nucleotide, being 0, -0, 1, -1, 2, and -2. For instance, 
in the 0 frame, the codons begins with the first nucleotide in the sequence.  In the 1 
frame, the codons begin with the second nucleotide in the sequence.  In the 2 frame, the 
codons begin with the third nucleotide in the sequence.  In the negative frames, instead of 
dealing with the normal 5' to 3' strand, the complement 3' to 5' strand is used.  When a 
different frame is used, called a frameshift, this can radically affect the outcome of the 
amino acids within the created protein, which can cause a non-functional protein.  An 
example of all six frameshifts can be found below in Table 1.  In this figure, adjoining 
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codons are spaced to differentiate the codons.  
 
Table 1: Demonstration of all six frameshifts of a nucleotide sequence 
Frame Nucleotide Sequence Translation 
1 GCCTATGC AY 
2 CCTATGC PM 
3 CTATGC LC 
-1 GCATAGGC A(STOP) 
-2 CATAGGC HR 
-3 ATAGGC IG 
 
 
 Within an organism, codons coding for the same amino acid will not always be 
used equally.  In fact, in many organisms, some specific codons will be preferred over 
others when coding for a single amino acid.  This is called codon bias.  Codon bias 
happens due to transfer RNA (tRNA).  This molecule helps construct the protein by 
adding an amino acid to the protein chain being assembled.  There are 64 different 
tRNA's possible, each with the complementary sequence for a given codon.  In a cell, it is 
more efficient to prefer one codon over another if they code for the same amino acid 
because it means that one tRNA can be produced more than others [12].   
 The proteins that are coded by genes are needed in performing activities within 
the cell.  One such example is an enzyme.  An enzyme has an active site that is specific to 
a molecule.  Once the specific molecule is attached, an action is performed.  For instance, 
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a molecule could have an active group cleaved.  Another function a protein can provide is 
structure.  For example, this could be hair, fur, or chitin.  Proteins for a particular 
organism are most often not unique to that organism.  In fact, across many species, a 
particular protein could exist.  This is called conservation.  Conservation does not only 
apply to entire proteins; it may also apply to amino acids within a protein, genes or even 
subsequences of the genome of an organism.  A conserved protein or sequence means this 
is very beneficial to the organism's survival or perhaps even lethal in its absence.  Within 
a genome, a special class of conservation exists.  This is called synteny.  Synteny is the 
conservation of gene order [35].  The order conserved can be forward or backwards, 
provided that the order is maintained.  All possible ways that synteny can exist is shown 
below in Figure 3.   
 
Protein p Protein i Protein q
Protein m Protein k Protein n
Protein set 1
Protein set 2
Protein xProtein iProtein yProtein set 3
Protein v Protein tProtein wProtein set 4
 
Figure 3:  Demonstration of synteny.  Protein sets 1, 2 and 3 exhibit synteny while protein 
set 4 does not exhibit synteny with any other protein set 
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 Within a protein, there are four different types of structure.  The first is primary 
structure.  This is only the sequence of amino acids of the protein.  The secondary 
structure is the structures that the amino acids as a result of being connected to each 
other.  There are two main secondary structures.  They are alpha helix and beta sheet.  As 
the names suggest, the alpha helix is a helical structure and the beta sheet is a flat sheet of 
amino acids.  The tertiary structure is a three dimensional structure of the protein.  This is 
due to event such as the protein burying its hydrophobic residues within itself or the 
cysteine amino acid forming a disulfide bond with another cysteine.  Finally, the 
quaternary structure is how the subunits of the protein, called domains, fit together.  
Domains are a structure that is often repeated within multiple proteins that most often 
have a function associated with them, such as ion channels and active sites [13]. 
 Domains are an important part of discovering what a protein does.  In fact, protein 
function can usually be summarized by the domain(s) that the protein contains.  Most 
often, these domains are conserved amongst homologous proteins.  The function of a 
domain within a protein is crucial for the protein to be of use within the cell.  Currently, 
there is a database called the Conserved Domain Database (CDD) that contains well 
studied domains [13].  If a domain is found within the CDD, it will have annotations 
explaining exactly what that domain is responsible for within a protein.   
 While domains are important within a protein, the individual amino acids carry a 
certain weight towards its characteristics.  One example of this is the charges provided by 
individual amino acids.  These are either positively charged or negatively charged.  These 
contribute to the total electric charge of the protein.  When a protein is in a solution, the 
charge is affected by the pH of the solution.  The point in which the charge of the protein 
10 
 
` 
 
is neutral is called the isoelectric point.  This property is important because proteins with 
certain isoelectric points will be localized to certain areas within the cell [14].  This idea 
can be expanded to protein function.  Proteins with similar function will be localized to a 
similar location.  Because of this, the proteins will have a similar isoelectric point.  
Inversely, if two proteins have the same isoelectric point, they may be located in the cell 
in similar locations. 
 
ALIGNMENTS 
 In bioinformatics, sequences can be compared to each other using an alignment.  
An alignment is a way to compare protein or DNA sequences.  An alignment is 
accomplished by laying two or more sequences side by side so that the best match 
between them is accomplished.  By adding gaps and shifting parts of the sequences, a 
“best fit” is reached called the optimal alignment.  An alignment enables the 
bioinformatist to show structural or functional similarities between the sequences [15].  
There are two main ways of aligning sequences, which are global and local alignments.  
By using a global alignment, the two sequences are compared as a whole [16].  To create 
the optimal alignment, gaps are introduced into either sequence.  A good example of a 
global alignment algorithm is the Needleman-Wunsch algorithm[16].   
 A local alignment differs from a global alignment by focusing on subsequences 
within the sequences being aligned that are identical or very similar [17].  It is from these 
subsequences that match that the alignment is built around.  From here, gaps are 
introduced into both sequences to allow an optimal alignment.  A good example of a local 
alignment algorithm is the Smith-Waterman algorithm [37].  It is actually from this local 
algorithm that the famous BLAST algorithm [17] is based.   
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 BLAST is most likely one of the most influential algorithms within 
bioinformatics.  BLAST was developed by National Center for Biotechnology 
Information (NCBI) as a way to find sequences that align closely with a query sequence 
[17].  BLAST can be used with both nucleotide and protein sequences.  This is done by 
dividing the query sequence into words of a certain length (k-mers).  For DNA sequences, 
this length is usually 11 nucleotides.  Regions within sequences that are repetitions of the 
same elements are ignored.  From here, the database of sequences to be searched is 
examined for these same words.  Once a sequence with an identical word is found, this 
word is extended in both sequences, at both sides of each subsequence.  These words are 
extended as long as the aligned words are above a certain predefined cutoff score.  From 
here, these matching words or high-scoring pairs, as the BLAST documentation call 
them, from the same sequence are combined to create alignments.  For each alignment 
created, a number called the E value is given.  The E value [38] is a measure of how close 
the aligned sequences are, by showing the number of times an unrelated sequence in the 
database would be aligned in this way by chance.  The lower E value is for the hit 
sequence, the better the alignment will be between the two sequences. 
 BLAST itself is actually just the basic algorithm in a series of programs provided 
by NCBI.  Amongst them are BLASTN and BLASTP which work with nucleotides and 
proteins respectively.   There are also related programs such as PSI-BLAST and RPS-
BLAST.  In the case of PSI-BLAST, this uses the results of a BLASTP search against a 
database to create a matrix that shows the conservation between the alignments [18].  
This can find divergent evolutionary relationships.  In the case of RPS-BLAST, a number 
of matrices like those generated in a PSI-BLAST, are queried against a reference 
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sequence [19].  This allows the user to find conserved evolutionary motifs within the 
sequence, such as domains. 
 
AUTOMATED ANNOTATION METHODS 
 In the world today, there are many different pipelines that are used in the 
automatic annotation of putative proteins from prokaryotic organisms [7, 20].  Despite 
the differences in algorithms, these pipelines there are two major steps involved in 
protein annotation.   
 The first step in the annotation process is gene finding, or structural annotation [7, 
20].  Most gene finding algorithms make use of Markov models to help predict genes.  A 
Markov model is a series of states, with the first n states determining the probability of 
the next given state.  For a Markov model of n order, the previous n states in the sequence 
are used to predict the next state.  Within a DNA sequence, each of the nucleotides is a 
state.  An example could be a 5
th
 order Markov model with the current sequence of 
nucleotides being ATGTA.  The probability that the the next nucleotide will be a A or a G 
is most likely going to be much lower than the probability that the next nucleotide will be 
a C or a T.  To use a Markov model, it must be trained by using a set of data in which it 
can discover the probability of each base after every possible set of n bases.  For the 
Markov model to work, it needs to have 4
n+1
 probabilities calculated.  As the order gets 
higher, this is much more demanding, as each of the sets of n +1 bases are required.  Due 
to this problem, one gene finder has dominated the field.  This gene finder is GLIMMER 
[7].  GLIMMER uses an Interpolated Markov model (IMM), rather than a normal 
Markov model.  IMMs hold an advantage over normal Markov models due to the number 
of states required to be calculated a given probability of the next state.   For instance, if 
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the current sequence contains AGT, and the probability calculated from a 3
rd
 order model 
that the next state will be G is the same probability as if the current sequence contains GT 
as a 2
nd
 order model, there is no benefit to training the model to the 3
rd
 order over the 2
nd
.  
This enables GLIMMER to only have to use larger order models on individual rare cases 
[20].   
 The second step in the annotation process is functional annotation [7,21].  Several 
tools are available here to find an annotation previously defined that fits the unannotated 
protein like BLAST, BLAST Extended Repraze (BER), InterPro, and hidden Markov 
models.  Of these methods, the simplest is BLAST.  In this context, a simple BLASTX 
search from the putative gene's nucleotide sequence or a BLASTP search from the 
putative gene's protein sequence against a protein database would potentially find 
homologous proteins and therefore give a functional annotation for the putative gene in 
question.  The next method, BER helps correct some of the errors within the putative 
gene, such as frameshift mutations and premature stop codons as well as extending the 
nucleotide sequence by adding additional bases on both of the upstream and downstream 
ends of the gene [7].  This can be especially helpful in cases where the organism in which 
you sequenced the DNA expressed a rare phenotype caused by a mutation like this.  To 
use a HMM to find functional annotations, first HMMs are trained from known members 
that share a specific function.  Next the putative gene is scored from the HMM.  If this 
gene score highly enough within the HMM, it can be considered a member of the family.  
The next tool that can be used to discover functional annotation is a database such as 
InterPro.  These databases house multiple sequence alignments on a single feature [22].  
This feature may be a domain, site, or a shared functional family.  
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 Each of these steps is critical in the current execution of an automatic annotation 
pipeline.  Currently there are many different automated annotation pipelines in 
production.  Among them are the IGS annotation engine [7] and the J. Craig Venter 
Institute (JCVI) annotation service [6].  To predict a correct protein annotation using the 
IGS pipeline, GLIMMER and RNA prediction are used to find the structural annotations 
while BLAST variants, BER, and HMMs are used to find functional annotations.  The 
data gathered in each step is then used to determine whether the protein is hypothetical or 
has enough supporting data to be considered a true protein.  When the JCVI pipeline is 
used to predict protein annotations, GLIMMER identifies putative genes within a 
genomic sequence that are thought to encode proteins.  Next, BLAST, BER, HMMs are 
used to compare these with existing families of proteins.  If a putative protein fits a 
family profile, it is considered to be part of the family.  
 
PUBLIC DATABASES 
Conserved Domain Database 
 The Conserved Domain Database (CDD), as the name suggests, is a database 
containing domains conserved and repeated across many different proteins.  This 
database has been collected and manually curated by the National Center for 
Biotechnology Information (NCBI) to ensure complete accuracy [13].  Using Entrez, this 
database is linked to other NCBI databases.  These domains are three dimensional 
structures within proteins that can help determine the protein’s function within the cell.  
The CDD first began as a mirror of other popular domain databases, such as Pfam.  Pfam 
is a domain databases that contain profile Hidden Markov Models for different domain 
families built from multiple sequence alignments [23].  The CDD has since differentiated 
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itself from databases like Pfam by using domain hierarchies.  For instance, a protein may 
match many domain Hidden Markov Models from Pfam, but only a small number of 
domain Hidden Markov Models from CDD [13].  This is because the profile Hidden 
Markov Models in Pfam can be based on sequences aligned on many properties.  For 
instance, this could be a common structural domain between proteins that have very 
different functions.  To avoid this pitfall, the CDD uses a hierarchical grouping of protein 
domains.  The protein in question is compared to a tree of domain profile Hidden Markov 
Models, so that the search starts out broad, but ends up on a specific set of domains.  The 
CDD is available for download onto local systems via an FTP site.  The database can be 
created on a local machine by using the “formatrpsdb” command within the NCBI 
Software Development Toolkit.  
  
GenBank 
 GenBank is a public database curated by NCBI [24].  This database holds protein 
and DNA sequences submitted by both large and small laboratories, as well as their 
annotations.  Sequence can be obtained as proteins, nucleotides, or even whole genomes.  
GenBank is accessible by the Entrez, which allows users to search for sequences as well 
as do BLAST searches.  All of the data that is available online is also available to be 
downloaded locally via an FTP site.  The files within GenBank are in GenBank format, as 
seen in Appendix A.  Files in GenBank format contain biological annotations as well as 
bibliographical annotations surrounding the sequence(s) in question.  As of February 
2012, there were 1,498,192,468 total sequences in GenBank [1]. 
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PROGRAMMING LANGUAGES 
 
Perl 
 Perl is an interpreted programming language developed by Larry Wall in the late 
1980's [25].  The original purpose of this programming language was to process reports, 
making this language efficient at processing text.  Perl became popular language to use 
due to its ease of use, partially due to the lack of type checking used in other scripting 
languages [26].  By having most all primitive data types interchangeable as a single type, 
the scalar, this saves developer’s time.  In the bioinformatics realm, this programming 
language has widespread use, most likely due to the ease of learning, the available code 
modules on the Internet, and most importantly, the ability to easily deal with text 
documents.  The ability to deal with text is especially important within bioinformatics 
because this is the format of most all publicly available data.   
 
BioPerl 
 While Perl is very helpful within bioinformatics, this results in many different 
users doing the same thing, while all writing different code to do this.  To solve this 
problem, a collection of Perl modules called BioPerl have been created to help within the 
bioinformatics domain [27].  To accomplish this, BioPerl uses an object oriented 
approach.  For example, in the SeqIO module, an annotated sequence can be read from a 
file into an object in memory.  From memory, methods can be called to view the 
properties of a sequence.  BioPerl solves many bioinformatics problems, such as parsing 
files, indexing databases, and using other bioinformatics tools like BLAST.  By having 
modules such as BioPerl, this saves developers a great deal of time, as code does not need 
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to be written a second time. 
 
MySQL 
 MySQL is an open source relational database management system [34].  It uses 
the SQL query language to perform database transactions. 
METHODS 
 
Overview 
 The main goal of WRAPS is to input annotated proteins specified by the user and 
to output a score that indicates how likely the protein for which it codes is properly 
annotated.  To accomplish this goal, this system is divided into four discrete sections.  A 
simplified outline of this system can be found in Figure 4.  A more in-depth diagram of 
this system can be found in Appendix B, as well as diagrams for each of the scripts that 
help set up and execute WRAPS. 
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Create Database
Populate Database
Run Evidence Tests on each Protein
Find weights of each Genus Group
Score Proteins
 
Figure 4: Structure of WRAPS 
 
 The first step in WRAPS is database population.  This step involves placing 
information for each protein sequence into several tables within the MySQL database.  
An entity relationship diagram for the database can be found in Appendix C.  To 
accomplish this, two Perl scripts are organized in a master-slave format, so that database 
population can be easily parallelized.  The first script handles user input.  The user inputs 
database credentials, the name of the database to be populated, and the directories in 
which the sequence data, in GenBank format [39], is located.  An example of a file in the 
GenBank format can be found in Appendix D.  This script recursively descends into the 
directories to find all possible files that have valid GenBank extensions (.seq, .gbk).  It 
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then reads a configuration file to find the host location and the maximum number of 
allowed child processes to use.  For each file in the input directories, a child process is 
spawned which runs a second script through use of the fork system call.  The second 
script uses BioPerl to parse the GenBank file and extract data pertaining to each coding 
sequence within the genome.  This extracted data is inserted into the specified MySQL 
database.  Once the maximum number of slave processes has been created, the master 
process waits until one of the slave processes has died.  Once a slave has died, the master 
will create another slave process to run the second script upon the next file.  This process 
continues until all of the valid GenBank files have been processed by the second script. 
 The second section of WRAPS tests each protein upon the evidence criteria.  This 
step involves reading information from the MySQL database protein entries, performing 
tests upon the data, and inserting a value indicating the outcome of each evidence test on 
each protein.  This is implemented in a series of Perl scripts.  This section is also 
structured in a master-slave format.  The first Perl script, the launcher, reads user 
information, being the database credentials and the database to be used.  When the 
launcher script runs, it reads from the WRAPS configuration file the number of slave 
processes to use and the number of proteins that have been populated within the selected 
database.  For each protein, the launcher executes a fork system call and executes an 
instance of a second Perl script, the evidence caller.  A number of slave processes are 
created by the launcher and limited to the maximum number of slave processes specified 
in the configuration file.  When a slave process dies, a new slave process is spawned to 
run the evidence caller script upon the next protein until all of the proteins have been run 
with the evidence caller script.  Within the evidence caller script, a series of scripts from a 
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designated directory is called on the specific protein in question.  Each of the called 
scripts atomically runs a single evidence test upon the protein and returns “PASS” if the 
protein passed the evidence test and “FAIL” if the protein failed the evidence test.  The 
individual evidence tests will be discussed more thoroughly later in this paper.  After each 
evidence test is completed, the result, a MySQL script is created to record the outcome of 
the evidence test upon the protein the script was run.  This is not immediately inserted in 
database as any evidence test results do not affect any other evidence test results, so the 
results of each evidence test can be recorded into the database after the completion of all 
evidence tests upon each protein.  By using this practice, the I/O load on the disk is 
considerably lessened, which allows the parallel evidence testing processes to analyze 
proteins faster. 
 For third section of WRAPS the evidence weights associated with each family of 
related sequence are calculated.  This is done by a Perl script.  Each group of related 
sequences is grouped by genus.  For instance, Yersinia pestis and Yersinia 
pseudotuberculosis will both be grouped in the Yersinia family.  Using the number of 
proteins that have passed the evidence tests within the positive control the weights will be 
calculated.  The actual equation used to calculate the weights will be discussed later in 
this paper. 
 In final section of WRAPS, the scores for each protein are calculated.  This is 
done by a pair of Perl scripts.  This section is structured in a master-slave format, with the 
first Perl script using the fork system call to assign a unique protein to the second Perl 
script within each slave process.  The method used to calculate the score will be 
discussed later in this paper. After WRAPS has been run, the resulting scores for each 
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protein can be found in the MySQL database.   
Parallelization 
To parallelize WRAPS, a simple method involving the "fork" system call was 
used.  By running the WRAPS launcher script a pool of child processes are spawned in 
which each child process handles the evidence test evaluations for a single protein.  This 
enables WRAPS to run much faster than only evaluating evidence tests in series.  Since 
the output of one evidence test affects no other concurrently running evidence tests, this 
effectively compartmentalizes individual proteins.  This is advantageous as the failure of 
the evaluation of the evidence tests on a single protein does not affect the evaluation of 
the evidence tests upon any other protein.  Due to the atomic nature of the evidences tests 
used upon each protein, this allows for very simple implementation.  In the launcher 
script, the parent process keeps spawning child processes to evaluate proteins.  The parent 
will keep track of the number of children it has while only spawning up to a user defined 
limit.  Once that limit is reached, the parent will wait until a child has died, and then 
spawn the next process.  This process is repeated until there are no additional proteins to 
be tested.  After this, the parent waits for its child processes to die before terminating as 
to avoid "zombie" processes.   
 
Evidence 1 
 The first evidence is to search the protein against the Conserved Domain Database 
(CDD) by using rps-blast. The structure of this evidence can be found in Figure 3. For a 
protein, its three dimensional structure is made up of smaller functional units called 
domains [13,28]. The CDD is a database that contains domains that are evolutionarily 
important to different organisms that are considered correct [13]. The CDD is manually 
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curated, so it does not have the same failings as databases like GenBank. When a protein 
has a domain found within the CDD, this is an indication that this protein is correct, so it 
passes this evidence. When there are no hits for a protein, this is an indication that the 
protein is incorrectly annotated.  The structure of this evidence can be found in Figure 5. 
Protein i
RPS-BLAST against CDD
Was there a hit?
Pass Fail
Yes No
 
Figure 5: Structure of Evidence 1 
 
Evidence 2 
 The second evidence analyzes the protein’s corresponding genomic sequence.  A 
correct protein should have conserved domains within its current frame.  If a protein in a 
different frame contains a conserved domain, this indicates that the alternate frame is 
most likely the correct frame, meaning that the current annotation is incorrect. For this 
evidence each of the protein's nucleotides are translated in six different frameshifts being 
0, 1, 2, -0, -1, and -2.  An example each of the six possible frameshifts, with the codons in 
alternating colors, can be seen in Table 1. To avoid missing pieces of the alternate frames’ 
proteins, the flanking intergenic genomic sequences are added to the protein’s 
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corresponding genomic sequence.  If there is a domain found within any of the 
frameshifts, this is counted as failing the evidence. If there are no domains found within 
the frameshifts, then this protein passes the evidence. The structure of this evidence can 
be seen in Figure 6.  
Protein i
6-frame translation
RPS-BLAST against CDD
Are there any hits?
Pass Fail
No Yes
 
Figure 6: Structure of Evidence 2 
 
Evidence 3 
 The third evidence examines the synteny of protein, which provides the relative 
position of the protein in the organism genome and it expected to be conserved among 
similar organisms [29].  To evaluate the synteny, the strandedness and the order of protein 
will be evaluated. To determine if a protein exhibits similar synteny with its flanking 
protein sequences against a homologous protein with similar flanking sequences, each of 
the flanking sequences of the protein in question will be used in a BLAST search against 
a BLAST database made of proteins from the same genus as the proteins being tested. 
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For each hit from the protein on the 5' end of the protein being tested, it is matched up 
with each other protein hit from the protein on the 3' end. If any of these combinations of 
two proteins are flanking one protein, this protein's synteny is conserved and it passes this 
evidence. If it had failed, then the protein fails the evidence. The structure of this 
evidence can be found in Figure 7. 
 
Protein i
5' protein p 3' protein q
Proteins homologous to p Proteins homologous to q 
Do any pairing of proteins of these two sets flank a single protein?
Pass Fail
Yes
No
 
Figure 7 : Structure of Evidence 3 
Evidence 4 
 The fourth evidence views the codon bias of the protein. Recall that a codon is a 
set of three sequential bases from the previous section. Since there are four total bases 
and three bases comprise a codon, it is easy to see that there are 64 possible codons. 
However, there are only 21 amino acids for which can be coded for. This means that there 
are multiple codons which code for the same amino acid or stop codon.  There are 22 
different amino acids that can be produced from a given codon, which means each amino 
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acid or stop codon has an average of 3 ways that it can be coded.  This means a protein of 
100 amino acids could be coded by about 5 x 10
47
 different nucleotide sequences [30]. 
However, not all these codons will be evenly used to code for the same protein, as 
discussed before with codon bias. This is an evolutionary response to different forces 
such as GC content or limiting metabolic load due to tRNA synthesis [30,31].  By having 
a codon bias, an organism can produce more of the same tRNA to code for the same 
amino acid, resulting in less energy needed to differentiate tRNA molecule.  Between 
similar organisms, a similar codon bias is exhibited [30]. To show this similarity, an 
algorithm will be developed that clusters like proteins based on codon bias into a binary 
tree. The evidence 4 will be collected based on whether the protein will cluster with 
organism from the same genus. If a protein is clustered with its genus, then it passes the 
evidence, otherwise it will be considered to fail this evidence.  The structure of this 
evidence can be found in Figure 8. 
Protein i
Compute Bias
Is this bias closest to another organism in the same family?
Pass Fail
Yes
No
 
Figure 8: Structure of Evidence 4 
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Evidence 5 
 The fifth evidence analyzes the isoelectric point of the protein in comparison to 
the expected normal confines of isoelectric point.  This is found by using the Henderson-
Hasselbach equation [32]. To determine the isoelectric point of the protein an algorithm 
as described by Tabb having O(log(n)) time [32] will be implemented. Since most all 
proteins are expected to have and isoelectric point between 4 and 10, protein showing the 
isoelectric point outside of the range is expected to be wrongly annotated [33].   
 
Evidence 6 
 The final evidence analyzes the isoelectric point of the protein in comparison to 
other proteins from organisms of the same genus. Within a cell, proteins that have a 
similar location and function will have a similar isoelectric point [33]. By using a BLAST 
search, a set of homologous proteins are found within the genus. If any of those proteins 
matches the isoelectric point of the protein within a certain degree of error, then this 
protein passes the evidence, otherwise, the protein fails the evidence.  The structure of 
this evidence can be found in Figure 9. 
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Protein i
Find homologous proteins (BLASTP)
Do homologous proteins exhibit a similar isoelectric 
point? 
Pass Fail
Yes
No
 
Figure 9: Structure of Evidence 6 
 
Weighting 
 Finally, the overall score for any annotation will be decided based on a weighting 
system. The purpose of the weighting system is to give more emphasis to evidence that 
apply more strongly to a families.  For instance, a family may have an abnormally high 
isoelectric point average, but most all of the proteins within that family have domains that 
are recorded within the CDD.  In this case, the weight applied to Evidence 1 would be 
weighted more heavily, by receiving a larger multiplier and Evidence 5 would be 
weighted less heavily, by receiving a smaller multiplier.  To do this, each of the protein 
descriptions are checked to find a set of proteins that are known to be correctly annotated, 
known as the positive control.  If a protein has been given an Enzyme Commission 
number, this protein is considered correctly annotated and used within the positive 
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control.  The set of proteins belonging to the positive control are determined in the 
database population step.  For each genus, the frequencies of all passing evidence tests 
are summed together. To give the weight for each evidence test, the frequency of the 
number of proteins from the positive control passing evidence test is divided by the sum 
of all the frequencies for all evidences. This weight shows the importance of a given 
evidence property within a given genus. The equation for determining the evidence 
weights for a family can be found in Equation 1.  
 
 
 
 
Pci – Positive control protein i 
Wi – Weight for evidence test i 
bi – Binary coefficient for evidence i 
 
Scoring 
 To determine the score of an individual protein, the respective weight is 
multiplied by a coefficient based on whether the protein passed or failed the given 
evidence. The coefficient will be 0 if the protein failed and 1 if the protein passed. 
Finally, all of these products will be summed together to determine the protein's score. 
From this, one can determine how closely this protein is to being correctly annotated. By 
giving a score as opposed to a binary number, this can show which sequences need to be 
re-annotated there by increasing the reliability of sequence annotation. The equation for 
determining the score can be found in Equation 2. 
W i=
Pc i
∑
i=1
n
Pci
Equation 1a 
S=∑
i=1
n
W i bi
Equation 1b 
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Statistical Analysis 
 To examine each of the evidence tests and the data as a whole, a series of 
statistical tests were performed to determine the data’s statistical significance.  For each 
evidence test, a Chi-squared test [40] was performed, comparing the proportion of the 
proteins in the positive control passing the evidence test to the proportion of proteins not 
included in the positive control passing the evidence test.  The Chi-squared test compares 
an expected value to the observed value.  This test was chosen to examine the difference 
between the positive control set and the case study set.  Proportional values were used 
rather than the true frequencies, so that the large numbers did not skew the Chi-squared 
tests.  This Chi-squared test is to measure the representation of passed evidence tests in 
the positive control sample versus the representation in the case study sample.  For each 
set, the proportion of the positive control proteins passing the evidence (13356 samples 
tested) is compared against the proportion of the case study proteins passing the evidence 
test.  If the Chi-squared test shows a statistical significance between the positive control 
sample and the case study sample, this means that the quality examined within the 
evidence test is important for the validity of the protein.  If the Chi-squared test is shown 
to be not statistically significant, then we must conclude that there is no significant 
difference in the pass rate for that particular evidence test between the positive control 
and the case study, showing that this evidence is a weak identifier for protein validity. 
In addition to the Chi-squared test, a two-sampled, two tailed Z-test [41] was used 
to compare the distributions of scores.  This test enables the comparison of each set of 
protein scores to each other, based upon the standard deviations.  This test was chosen to 
compare the ranges of scores of the positive control and the case study sets.  Rather than 
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only comparing a single facet of the score, this test enables us to see the entire ranges of 
scores.  If the Z-test shows a statistical significance between the two sets of scores, and 
the z-value is positive, this shows that there is a clear difference between the positive 
control samples and case study samples, meaning that there is an increased level of 
correct proteins in the case study samples compared to the positive control samples.  If 
the Z-test shows a statistical significance between the two sets of scores, and the z-value 
is negative, this shows that there is a clear difference between the positive control 
samples and case study samples, meaning that there is a decreased level of correct 
proteins in the case study samples compared to the positive control samples.  If the Z-test 
shows no statistical significance between the two sets of scores, and the z-value is 
negative, this shows that there is no clear difference between the positive control samples 
and case study samples. 
RESULTS AND DISCUSSION 
 WRAPS was used to analyze 88,023 proteins belonging to the Yersinia, 
Staphylococcus, and Bacillus genera available on University of Nebraska at Omaha's 
KLAB server, which partially serves as a database for all bacterial genomes found in 
January 2011 version of GenBank.  For this set, 13356 proteins have been manually 
annotated, both structurally and functionally.  In Appendix A, a table of the results of 
each possible outcome from the evidence tests can be found.  For this set, the positive 
control set was used as a template for which to predict the whole set.  From this, the 
amount in each category was expected to grow in proportion equal to the magnitude of 
the increase in size of the test set.  We would expect this because of the protein homology 
that exists within closely related prokaryotes.  In the prokaryotes used in the study, such 
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as Yersinia pestis, these organisms have many proteins existing within the positive 
control.  In closely related organisms, we would expect that homologous proteins would 
be found within the genomes.  These homologous proteins would be expected to exhibit 
the same properties as their cousins within the positive control.  However, viewing the 
difference in sizes between the expected column and the observed column, it is clear that 
the data set  is not as correctly annotated as the positive control set.   
 To help with the understanding of this data, I submit two terms.  The first term to 
be defined is evidence class.  This is row in the table, representing a single possible 
outcome on all of the evidence tests, which can be expressed by a bit string.   For 
instance, score class could be passing the first evidence test, passing the second evidence 
test, failing the third evidence test, passing the fourth evidence test, passing the fifth 
evidence test and failing the sixth evidence test, which would result in a bit string of 
110110.  In total, there are 64 possible evidence classes, as there are two discrete possible 
outcomes of each evidence test.  The second term to be used within the context of this 
data is annotational correctness.  This is represented by the score given.  A higher score 
shows that an evidence class shows a higher annotational correctness.  It should also be 
noted that the table is ordered by the evidence classes, not the annotational correctness.  It 
is important to note that proteins within the positive control may belong to evidence 
classes which have a lower level of annotational correctness than others.  In the case of 
the positive control, this is the data in which the weighting system is trained.  Even 
amongst correctly annotated proteins there will be variance.  However, the variance 
between annotational evidence classes in the whole data set will vary much more, as we 
would image that proteins are missanotated within the set.  
32 
 
` 
 
 In this data set, it should be noted that the proportions that the different evidence 
class are zero-sum, meaning, for every decrease in a single evidence class's proportion, 
one or more other evidence classes must increase in proportion within the data set.   In 
the system presented, the addition of unverified proteins drops the frequency of evidence 
classes corresponding to more correct annotations, with an increase in the frequency of 
evidence classes corresponding to less correct annotations.  To introduce a change in 
evidence class frequency, this would be caused by the additional passing or failing from 
the evidences.  For each of the evidence class frequencies that decrease in comparison to 
the positive control, this is due to the failure of more evidence tests, as noted by the 
general decrease in the annotational correctness of the entire data set when compared to 
the positive control.  For the frequency of a higher annotational correctness evidence 
class to drop and the frequency of a similar evidence class of lesser annotational 
correctness, it is more probable that a single test was failed rather than the multiple tests.  
When examining evidence classes, such as 111111 and 1111110, it can be seen that there 
is a decrease in proportion of proteins at this evidence class when compared to the 
positive control.  It should be noted that when comparing these two bit strings to 111101 
and 111100 respectively, the evidence classes that are different from the first two 
evidence classes by failing evidence 5.  This can also be observed for many of the other 
evidence classes exhibiting a high annotational correctness.  For the evidence tests 
needed to fail to change the frequencies of evidence classes, evidence 1 and 5 were failed 
the most.  This mirrors the weights assigned to the individual evidences, as the weights 
assigned to evidence 1 and 5 are the highest of all evidences.  This shows that these 
properties tested by the evidence 1 and 5 give a protein a higher degree of annotational 
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correctness than other properties, and are properties exhibited in correctly annotated 
proteins.  Table 2, which is a table of the weights calculated along with the sensitivity and 
the number of proteins from each of the evidence test passing from both the full data set 
and the positive control.  For the tests, it was not possible to calculate the specificity of 
the tests, as there are no known negatives without testing in a laboratory, since known 
wrongly annotated proteins would not be knowingly inserted into GenBank.  In a side 
experiment, randomly generated DNA sequences were used to synthesize proteins to be 
tested.  However, in each of the 1000 sequences generated, each failed every evidence 
test but evidence 2. 
 
Table 2: Weights, and sensitivity of positive control data 
  Bacillus Staphylococcus Yersinia Positive Control Sensitivity 
ev1 0.301 0.295 0.246 13332 0.998203 
ev2 0.071 0.055 0.046 2563 0.191899 
ev3 0.036 0.013 0.102 3775 0.282645 
ev4 0.142 0.259 0.202 10784 0.807427 
ev5 0.299 0.288 0.240 13017 0.974618 
ev6 0.150 0.088 0.162 7208 0.539683 
 
 Based on the evidence presented, the most important properties that were known 
domains as shown by evidence 1, having an isoelectric that fits a typical range as shown 
by evidence 5, and by having a codon bias that is also expressed by another member of 
the same genus.  In the case of evidence 1, it was quite obvious how important having a 
well-known domain, as in the evidence class table, as there are hardly any proteins that 
did not contain a domain not known to the CDD.  In the case of evidence 5, it was not 
nearly as pronounced as evidence 1, but when viewing the evidence class table, there is a 
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significant drop in the frequency of evidence class members in the positive control 
whenever evidence 5 is failed when compared to the evidence classes that did pass 
evidence 5.  While this test is a good indication of a protein’s annotation’s correctness, I 
believe that it could be refined so that it more reflects the individual organisms, as 
providing just a flat range of isoelectric may incorrectly fail the proteins from more 
extremophilic prokaryotes. In the case of evidence 4, it is shown much in the same way 
as evidence 5, but not nearly as pronounced.  This evidence can also be improved with 
adding more flexibility to the bias model, by allowing one or two mismatches between 
the protein's bias bit string and matching bit strings.  As a tradeoff, a certain number of 
matching strings would need to be able to be matched for the protein to pass this evidence 
test. 
 Despite the successes with evidence tests 1, 4, and, 5, evidence tests 2, 3, and 6 
admittedly need more work.  To begin, evidence test 3 is probably the hardest test of all 
of the evidence tests to be able to prove without, as to increase its lenience, would greatly 
increase its complexity.  One such way would be to allow small numbers of proteins 
within the proteins exhibiting synteny.  In the case of evidence 6, this evidence test 
suffers from the unproven functional annotations.  To improve this, rather than finding a 
homologous protein from all of the proteins within the database, only homologous 
proteins from the positive control should be used.  This would ensure that homologous 
proteins that are found truly have a homologous function.  The final sub-par evidence as 
shown by the execution of the system is evidence 2.  Unlike its sister evidence, evidence 
1, it is a negative evidence, so rather than looking for the presence of the domains, it is 
looking for the absence in the alternate frames.  To improve this evidence, the genomic 
35 
 
` 
 
location of domains can be noted and queried against the database.  In the case that 
proteins would overlap, this could be checked so that finding true protein within another 
true protein would not constitute a failure.   
Table 3: Chi-Squared test on each evidence test against the positive control 
Evidence Test Positive Control vs All 
Proteins 
Positive Control vs Case 
study 
1 P = 4.90e-5 P = 1.71e-6 
2 P = 0.83 P  = 0.80 
3 P = 0.92 P = 0.90 
4 P = 0.88 P = 0.85 
5 P = 0.49 P = 0.41 
6 P = 0.84 P = 0.81 
 
 Examining the Chi-squared tests (Table 3), the difference in correctness in the 
positive control samples and the case study samples was shown to be statistically 
significant in evidence test 1.  In the other evidence tests, the difference positive control 
proteins and the case study proteins was shown to be not statistically significant.  The 
results from these Chi-squared tests, show us that there is a significant difference only in 
the conserved domains located in the positive control proteins and the case study proteins 
suggesting that the case study samples are enriched with incorrect annotations.  Since we 
are almost certain that the case study set contains incorrectly annotated proteins, we must 
conclude that this is the reason for the decreased proportion in the proteins passing this 
evidence.  This confirms to us that having a domain that is known to be correct is a 
defining feature within correctly annotated proteins.   
In the other evidence tests, this shows that there is no significant difference 
between the case study proteins and the positive control proteins.  While these results 
may seem to show that evidence tests 2, 3, 4, 5, and 6 do not matter between sets of 
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correctly annotated and incorrectly annotated proteins, it is important to note that we do 
know the true annotations of the case study proteins.  It is extremely likely that many of 
these proteins are correctly annotated.  If we use any evidence test on any two sets of 
correctly annotated proteins, we would expect that there should be no statistically 
significant difference between the result of either evidence tests.  In the sample sets used, 
the ratio of incorrectly annotated proteins to total sample set can easily change the 
statistical significance of the evidence tests.  In addition to the makeup of the case study 
set, the statistical insignificance of the case study set may also be due to the tuning of the 
individual evidence tests.  For instance, a minority of both the positive control and the 
case study passed evidence test 3.  This lack of passed tests is also reflected within the 
sensitivity shown in Table 2.  This suggests that this evidence test is too stringent.  To 
correct this, it could be changed to allow a number of other genes within the genes 
exhibiting synteny (within a threshold), as long as the three proteins exhibiting synteny 
maintain their order. 
 
Table 4: Z-test of protein scores 
 z-value P-value 
Case study vs Positive 
Control -81.99003069 P≈0 
All proteins vs Positive 
Control -41.98363913 P≈0 
 
 Examining the results of the Z-test (Table 4), shows that the difference between 
the case study proteins and the positive control is statistically significant.  A histogram 
showing the amount of proteins relative each of the 64 possible scores can be seen below 
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in Figure 10.  In this histogram, it is plain to see that there is a reduction in the scores 
when comparing the case study set to the positive control set.  This reduction in scores 
and a statistically significant difference suggest that there are wrongly annotated proteins 
within the case study data set.  When adding this to the analysis done with the Chi-
squared test, this suggests that while only one evidence test was statistically significant, 
the aggregation of all of the evidence tests show that there is a larger difference between 
the positive control data set and the case study data set. 
 
 
Figure 10: Histogram of scores from positive control and case study proteins 
 
 In pipelines currently being used in sequencing today, the data generated from 
WRAPS would greatly improve the quality of the annotated sequences that are released.  
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While I do not believe WRAPS will be adopted by many, if any pipelines, the tests 
adapted within it can be used within current protein annotation pipelines.  By using an 
automated method that quickly and efficiently identifies possible missanotated proteins to 
pipelines, this brings a dramatic increase in speed compared to traditional wet-lab protein 
annotation, and more accuracy to the current methods of automated annotation. 
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APPENDIX A 
ev1 ev2 ev3 ev4 ev5 ev6 Yersinia Staphylococcus Bacillus Avg. Score Pos. Control Expect Observed Obs. Growth/Expect 
0 0 0 0 0 0 0.00 0.00 0.00 0.00 7 46 496 10.75 
0 0 0 0 0 1 0.15 0.30 0.29 0.25 0 0 222 NA 
0 0 0 0 1 0 0.30 0.29 0.22 0.27 1 7 943 143.08 
0 0 0 0 1 1 0.45 0.59 0.51 0.51 0 0 498 NA 
0 0 0 1 0 0 0.14 0.03 0.08 0.08 2 13 280 21.24 
0 0 0 1 0 1 0.29 0.33 0.37 0.33 0 0 370 NA 
0 0 0 1 1 0 0.44 0.31 0.31 0.35 4 26 936 35.51 
0 0 0 1 1 1 0.59 0.61 0.59 0.60 1 7 1106 167.82 
0 0 1 0 0 0 0.04 0.06 0.26 0.12 0 0 34 NA 
0 0 1 0 0 1 0.19 0.36 0.55 0.37 0 0 17 NA 
0 0 1 0 1 0 0.33 0.34 0.49 0.39 0 0 74 NA 
0 0 1 0 1 1 0.49 0.65 0.77 0.63 0 0 23 NA 
0 0 1 1 0 0 0.18 0.08 0.35 0.20 0 0 15 NA 
0 0 1 1 0 1 0.33 0.39 0.64 0.45 0 0 24 NA 
0 0 1 1 1 0 0.48 0.37 0.57 0.47 0 0 24 NA 
0 0 1 1 1 1 0.63 0.67 0.86 0.72 0 0 130 NA 
0 1 0 0 0 0 0.07 0.30 0.07 0.15 0 0 473 NA 
0 1 0 0 0 1 0.22 0.60 0.35 0.39 0 0 258 NA 
0 1 0 0 1 0 0.37 0.59 0.29 0.41 3 20 2081 105.25 
0 1 0 0 1 1 0.52 0.89 0.57 0.66 0 0 891 NA 
0 1 0 1 0 0 0.21 0.33 0.15 0.23 0 0 533 NA 
0 1 0 1 0 1 0.36 0.63 0.44 0.48 0 0 434 NA 
0 1 0 1 1 0 0.51 0.61 0.37 0.50 0 0 1882 NA 
0 1 0 1 1 1 0.66 0.91 0.66 0.75 2 13 1632 123.81 
0 1 1 0 0 0 0.11 0.36 0.33 0.27 0 0 88 NA 
0 1 1 0 0 1 0.26 0.66 0.62 0.51 0 0 55 NA 
0 1 1 0 1 0 0.41 0.65 0.55 0.53 2 13 286 21.70 
0 1 1 0 1 1 0.56 0.95 0.84 0.78 0 0 207 NA 
0 1 1 1 0 0 0.25 0.39 0.42 0.35 0 0 26 NA 
0 1 1 1 0 1 0.40 0.69 0.70 0.60 0 0 155 NA 
0 1 1 1 1 0 0.55 0.67 0.64 0.62 0 0 213 NA 
0 1 1 1 1 1 0.70 0.97 0.92 0.87 2 13 741 56.22 
1 0 0 0 0 0 0.30 0.03 0.08 0.13 17 112 559 4.99 
1 0 0 0 0 1 0.45 0.33 0.36 0.38 13 86 446 5.21 
1 0 0 0 1 0 0.60 0.31 0.30 0.40 868 5721 6007 1.05 
1 0 0 0 1 1 0.75 0.61 0.58 0.65 684 4508 2922 0.65 
1 0 0 1 0 0 0.44 0.05 0.16 0.22 87 573 1965 3.43 
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1 0 0 1 0 1 0.59 0.35 0.45 0.47 67 442 2254 5.10 
1 0 0 1 1 0 0.74 0.34 0.38 0.49 2989 19699 17690 0.90 
1 0 0 1 1 1 0.89 0.64 0.67 0.73 3191 21030 12456 0.59 
1 0 1 0 0 0 0.34 0.09 0.34 0.25 9 59 162 2.73 
1 0 1 0 0 1 0.49 0.39 0.63 0.50 4 26 129 4.89 
1 0 1 0 1 0 0.64 0.37 0.56 0.52 228 1503 1537 1.02 
1 0 1 0 1 1 0.79 0.67 0.85 0.77 252 1661 941 0.57 
1 0 1 1 0 0 0.48 0.11 0.43 0.34 29 191 474 2.48 
1 0 1 1 0 1 0.63 0.41 0.71 0.59 44 290 869 3.00 
1 0 1 1 1 0 0.78 0.40 0.65 0.61 730 4811 4675 0.97 
1 0 1 1 1 1 0.93 0.70 0.93 0.85 1566 10321 5567 0.54 
1 1 0 0 0 0 0.37 0.33 0.14 0.28 2 13 101 7.66 
1 1 0 0 0 1 0.52 0.63 0.43 0.53 2 13 94 7.13 
1 1 0 0 1 0 0.67 0.61 0.36 0.55 182 1199 1337 1.11 
1 1 0 0 1 1 0.82 0.92 0.65 0.80 141 929 635 0.68 
1 1 0 1 0 0 0.51 0.35 0.23 0.37 11 72 463 6.39 
1 1 0 1 0 1 0.67 0.66 0.51 0.61 22 145 518 3.57 
1 1 0 1 1 0 0.81 0.64 0.45 0.63 671 4422 4172 0.94 
1 1 0 1 1 1 0.96 0.94 0.74 0.88 614 4047 2453 0.61 
1 1 1 0 0 0 0.41 0.39 0.41 0.40 4 26 37 1.40 
1 1 1 0 0 1 0.56 0.69 0.69 0.65 1 7 33 5.01 
1 1 1 0 1 0 0.71 0.67 0.63 0.67 79 521 474 0.91 
1 1 1 0 1 1 0.86 0.97 0.92 0.92 73 481 279 0.58 
1 1 1 1 0 0 0.55 0.41 0.49 0.49 4 26 111 4.21 
1 1 1 1 0 1 0.70 0.71 0.78 0.73 14 92 191 2.07 
1 1 1 1 1 0 0.85 0.70 0.71 0.75 219 1443 1332 0.92 
1 1 1 1 1 1 1.00 1.00 1.00 1.00 515 3394 1993 0.59 
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APPENDIX B 
  
WRAPconfiguration.pl
WRAPS Settings
WRAPS.config
User credentials
WRAPcreate.pl
MySQL DB
Adds tables
Setting 
Configurations
Creating Database 
tables
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User credentials Start Protein
WRAPlauncher.pl
MySQL DB
WRAPS_start.pl
WRAPS_start.pl
ev1.pl
Protein id
ev2.pl evn.pl
MySQL DB
...
Pass/fail
Pass/fail
Pass/fail
wraps.sql
Evaluation of properties
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ev1.pl
MySQL DB
.faa file
CDDrpsblast
Result.xml
ev2.pl
MySQL DB
.faa file CDDrpsblast
Result.xml
6 frame translation
`
Get Protein
Get Protein
Evidence 1
Evidence 2
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MySQL DB
Get Proteins
ev3.pl
Protein 1 fasta
Protein 2 fasta
Evidence 3
Genus 
BlastDB
blastp
Results 1
Results 2 Find proteins that 
have p_ids differing by 2
Evidence 4
MySQL DB
ev4.plFind synonymous codon 
usage (same bit string)
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Evidence 5 MySQL DB
Get Protein
ev5.pl
Test isoelectric
range
MySQL DB
Get Protein
ev6.pl
Evidence 6
Genus 
BlastDB
blastp
Homologous 
proteins
Compare isoelectric point
Results
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APPENDIX C 
 
 
Legend 
genome.g_id – Identification number assigned to an individual GenBank file by the 
genome.database 
genome.gacc – Genomic accession number from GenBank 
genome.genus – Genus of the organism 
genome.path – path to GenBank file 
genome.ts – timestamp 
protein.p_id - Identification number assigned to an individual protein 
protein.g_id – foreign key referencing genome.g_id, corresponds to the genome in which 
the protein belongs 
protein.pacc – protein accession number 
protein.p_desc – description of the protein 
protein.start – nucleotide start position of the protein  
protein.end – nucleotide end position of the protein  
protein.strand_id – number assigned to sequential proteins on the same strand.  3’ to 5’ 
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strand is negative while the 5’ to 3’ strand is positive 
protein.pseq – protein sequence 
genweight.genus – genus for weighs 
genweight.wn – weight for evidence test n 
 
positive.p_id – protein id for positive control protein 
 
bias.p_id – protein id for protein 
bias.bit_string – bit string representing preferred codon usage 
bias.bit_num – number of codons in which the protein holds a bias for 
 
hom.p_id – protein id for protein 
hom.hom_id – protein id for homologous protein  
 
trans.p_id – protein id for protein 
trans.nseq – nucleotide sequence for protein 
 
intergenic.p_id – protein id for protein 
intergenic.p_id5 – 5’ neighboring protein (if any) 
intergenic.p_id3 – 3’ neighboring protein (if any) 
intergenic.inter5 – 5’ intergenic sequence 
intergenic.inter3 – 3’ intergenic sequence 
 
evn.p_id – protein id for protein 
evn.pass – Boolean variable representing protein passing (1) or failing (0) evidence n 
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Appendix D 
LOCUS       SCU49845     5028 bp    DNA             PLN       21-JUN-1999 
DEFINITION  Saccharomyces cerevisiae TCP1-beta gene, partial cds, and Axl2p 
            (AXL2) and Rev7p (REV7) genes, complete cds. 
ACCESSION   U49845 
VERSION     U49845.1  GI:1293613 
KEYWORDS    . 
SOURCE      Saccharomyces cerevisiae (baker's yeast) 
  ORGANISM  Saccharomyces cerevisiae 
            Eukaryota; Fungi; Ascomycota; Saccharomycotina; Saccharomycetes; 
            Saccharomycetales; Saccharomycetaceae; Saccharomyces. 
REFERENCE   1  (bases 1 to 5028) 
  AUTHORS   Torpey,L.E., Gibbs,P.E., Nelson,J. and Lawrence,C.W. 
  TITLE     Cloning and sequence of REV7, a gene whose function is required for 
            DNA damage-induced mutagenesis in Saccharomyces cerevisiae 
  JOURNAL   Yeast 10 (11), 1503-1509 (1994) 
  PUBMED    7871890 
REFERENCE   2  (bases 1 to 5028) 
  AUTHORS   Roemer,T., Madden,K., Chang,J. and Snyder,M. 
  TITLE     Selection of axial growth sites in yeast requires Axl2p, a novel 
            plasma membrane glycoprotein 
  JOURNAL   Genes Dev. 10 (7), 777-793 (1996) 
  PUBMED    8846915 
REFERENCE   3  (bases 1 to 5028) 
  AUTHORS   Roemer,T. 
  TITLE     Direct Submission 
  JOURNAL   Submitted (22-FEB-1996) Terry Roemer, Biology, Yale University, New 
            Haven, CT, USA 
FEATURES             Location/Qualifiers 
     source          1..5028 
                     /organism="Saccharomyces cerevisiae" 
                     /db_xref="taxon:4932" 
                     /chromosome="IX" 
                     /map="9" 
     CDS             <1..206 
                     /codon_start=3 
                     /product="TCP1-beta" 
                     /protein_id="AAA98665.1" 
                     /db_xref="GI:1293614" 
                     /translation="SSIYNGISTSGLDLNNGTIADMRQLGIVESYKLKRAVVSSASEA 
                     AEVLLRVDNIIRARPRTANRQHM" 
     gene            687..3158 
                     /gene="AXL2" 
     CDS             687..3158 
                     /gene="AXL2" 
                     /note="plasma membrane glycoprotein" 
                     /codon_start=1 
                     /function="required for axial budding pattern of S. 
                     cerevisiae" 
                     /product="Axl2p" 
                     /protein_id="AAA98666.1" 
                     /db_xref="GI:1293615" 
                     /translation="MTQLQISLLLTATISLLHLVVATPYEAYPIGKQYPPVARVNESF 
                     TFQISNDTYKSSVDKTAQITYNCFDLPSWLSFDSSSRTFSGEPSSDLLSDANTTLYFN 
                     VILEGTDSADSTSLNNTYQFVVTNRPSISLSSDFNLLALLKNYGYTNGKNALKLDPNE 
                     VFNVTFDRSMFTNEESIVSYYGRSQLYNAPLPNWLFFDSGELKFTGTAPVINSAIAPE 
                     TSYSFVIIATDIEGFSAVEVEFELVIGAHQLTTSIQNSLIINVTDTGNVSYDLPLNYV 
                     YLDDDPISSDKLGSINLLDAPDWVALDNATISGSVPDELLGKNSNPANFSVSIYDTYG 
                     DVIYFNFEVVSTTDLFAISSLPNINATRGEWFSYYFLPSQFTDYVNTNVSLEFTNSSQ 
                     DHDWVKFQSSNLTLAGEVPKNFDKLSLGLKANQGSQSQELYFNIIGMDSKITHSNHSA 
                     NATSTRSSHHSTSTSSYTSSTYTAKISSTSAAATSSAPAALPAANKTSSHNKKAVAIA 
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                     CGVAIPLGVILVALICFLIFWRRRRENPDDENLPHAISGPDLNNPANKPNQENATPLN 
                     NPFDDDASSYDDTSIARRLAALNTLKLDNHSATESDISSVDEKRDSLSGMNTYNDQFQ 
                     SQSKEELLAKPPVQPPESPFFDPQNRSSSVYMDSEPAVNKSWRYTGNLSPVSDIVRDS 
                     YGSQKTVDTEKLFDLEAPEKEKRTSRDVTMSSLDPWNSNISPSPVRKSVTPSPYNVTK 
                     HRNRHLQNIQDSQSGKNGITPTTMSTSSSDDFVPVKDGENFCWVHSMEPDRRPSKKRL 
                     VDFSNKSNVNVGQVKDIHGRIPEML" 
     gene            complement(3300..4037) 
                     /gene="REV7" 
     CDS             complement(3300..4037) 
                     /gene="REV7" 
                     /codon_start=1 
                     /product="Rev7p" 
                     /protein_id="AAA98667.1" 
                     /db_xref="GI:1293616" 
                     /translation="MNRWVEKWLRVYLKCYINLILFYRNVYPPQSFDYTTYQSFNLPQ 
                     FVPINRHPALIDYIEELILDVLSKLTHVYRFSICIINKKNDLCIEKYVLDFSELQHVD 
                     KDDQIITETEVFDEFRSSLNSLIMHLEKLPKVNDDTITFEAVINAIELELGHKLDRNR 
                     RVDSLEEKAEIERDSNWVKCQEDENLPDNNGFQPPKIKLTSLVGSDVGPLIIHQFSEK 
                     LISGDDKILNGVYSQYEEGESIFGSLF" 
ORIGIN 
        1 gatcctccat atacaacggt atctccacct caggtttaga tctcaacaac ggaaccattg 
       61 ccgacatgag acagttaggt atcgtcgaga gttacaagct aaaacgagca gtagtcagct 
      121 ctgcatctga agccgctgaa gttctactaa gggtggataa catcatccgt gcaagaccaa 
      181 gaaccgccaa tagacaacat atgtaacata tttaggatat acctcgaaaa taataaaccg 
      241 ccacactgtc attattataa ttagaaacag aacgcaaaaa ttatccacta tataattcaa 
      301 agacgcgaaa aaaaaagaac aacgcgtcat agaacttttg gcaattcgcg tcacaaataa 
      361 attttggcaa cttatgtttc ctcttcgagc agtactcgag ccctgtctca agaatgtaat 
      421 aatacccatc gtaggtatgg ttaaagatag catctccaca acctcaaagc tccttgccga 
      481 gagtcgccct cctttgtcga gtaattttca cttttcatat gagaacttat tttcttattc 
      541 tttactctca catcctgtag tgattgacac tgcaacagcc accatcacta gaagaacaga 
      601 acaattactt aatagaaaaa ttatatcttc ctcgaaacga tttcctgctt ccaacatcta 
      661 cgtatatcaa gaagcattca cttaccatga cacagcttca gatttcatta ttgctgacag 
      721 ctactatatc actactccat ctagtagtgg ccacgcccta tgaggcatat cctatcggaa 
      781 aacaataccc cccagtggca agagtcaatg aatcgtttac atttcaaatt tccaatgata 
      841 cctataaatc gtctgtagac aagacagctc aaataacata caattgcttc gacttaccga 
      901 gctggctttc gtttgactct agttctagaa cgttctcagg tgaaccttct tctgacttac 
      961 tatctgatgc gaacaccacg ttgtatttca atgtaatact cgagggtacg gactctgccg 
     1021 acagcacgtc tttgaacaat acataccaat ttgttgttac aaaccgtcca tccatctcgc 
     1081 tatcgtcaga tttcaatcta ttggcgttgt taaaaaacta tggttatact aacggcaaaa 
     1141 acgctctgaa actagatcct aatgaagtct tcaacgtgac ttttgaccgt tcaatgttca 
     1201 ctaacgaaga atccattgtg tcgtattacg gacgttctca gttgtataat gcgccgttac 
     1261 ccaattggct gttcttcgat tctggcgagt tgaagtttac tgggacggca ccggtgataa 
     1321 actcggcgat tgctccagaa acaagctaca gttttgtcat catcgctaca gacattgaag 
     1381 gattttctgc cgttgaggta gaattcgaat tagtcatcgg ggctcaccag ttaactacct 
     1441 ctattcaaaa tagtttgata atcaacgtta ctgacacagg taacgtttca tatgacttac 
     1501 ctctaaacta tgtttatctc gatgacgatc ctatttcttc tgataaattg ggttctataa 
     1561 acttattgga tgctccagac tgggtggcat tagataatgc taccatttcc gggtctgtcc 
     1621 cagatgaatt actcggtaag aactccaatc ctgccaattt ttctgtgtcc atttatgata 
     1681 cttatggtga tgtgatttat ttcaacttcg aagttgtctc cacaacggat ttgtttgcca 
     1741 ttagttctct tcccaatatt aacgctacaa ggggtgaatg gttctcctac tattttttgc 
     1801 cttctcagtt tacagactac gtgaatacaa acgtttcatt agagtttact aattcaagcc 
     1861 aagaccatga ctgggtgaaa ttccaatcat ctaatttaac attagctgga gaagtgccca 
     1921 agaatttcga caagctttca ttaggtttga aagcgaacca aggttcacaa tctcaagagc 
     1981 tatattttaa catcattggc atggattcaa agataactca ctcaaaccac agtgcgaatg 
     2041 caacgtccac aagaagttct caccactcca cctcaacaag ttcttacaca tcttctactt 
     2101 acactgcaaa aatttcttct acctccgctg ctgctacttc ttctgctcca gcagcgctgc 
     2161 cagcagccaa taaaacttca tctcacaata aaaaagcagt agcaattgcg tgcggtgttg 
     2221 ctatcccatt aggcgttatc ctagtagctc tcatttgctt cctaatattc tggagacgca 
     2281 gaagggaaaa tccagacgat gaaaacttac cgcatgctat tagtggacct gatttgaata 
     2341 atcctgcaaa taaaccaaat caagaaaacg ctacaccttt gaacaacccc tttgatgatg 
     2401 atgcttcctc gtacgatgat acttcaatag caagaagatt ggctgctttg aacactttga 
     2461 aattggataa ccactctgcc actgaatctg atatttccag cgtggatgaa aagagagatt 
     2521 ctctatcagg tatgaataca tacaatgatc agttccaatc ccaaagtaaa gaagaattat 
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     2581 tagcaaaacc cccagtacag cctccagaga gcccgttctt tgacccacag aataggtctt 
     2641 cttctgtgta tatggatagt gaaccagcag taaataaatc ctggcgatat actggcaacc 
     2701 tgtcaccagt ctctgatatt gtcagagaca gttacggatc acaaaaaact gttgatacag 
     2761 aaaaactttt cgatttagaa gcaccagaga aggaaaaacg tacgtcaagg gatgtcacta 
     2821 tgtcttcact ggacccttgg aacagcaata ttagcccttc tcccgtaaga aaatcagtaa 
     2881 caccatcacc atataacgta acgaagcatc gtaaccgcca cttacaaaat attcaagact 
     2941 ctcaaagcgg taaaaacgga atcactccca caacaatgtc aacttcatct tctgacgatt 
     3001 ttgttccggt taaagatggt gaaaattttt gctgggtcca tagcatggaa ccagacagaa 
     3061 gaccaagtaa gaaaaggtta gtagattttt caaataagag taatgtcaat gttggtcaag 
     3121 ttaaggacat tcacggacgc atcccagaaa tgctgtgatt atacgcaacg atattttgct 
     3181 taattttatt ttcctgtttt attttttatt agtggtttac agatacccta tattttattt 
     3241 agtttttata cttagagaca tttaatttta attccattct tcaaatttca tttttgcact 
     3301 taaaacaaag atccaaaaat gctctcgccc tcttcatatt gagaatacac tccattcaaa 
     3361 attttgtcgt caccgctgat taatttttca ctaaactgat gaataatcaa aggccccacg 
     3421 tcagaaccga ctaaagaagt gagttttatt ttaggaggtt gaaaaccatt attgtctggt 
     3481 aaattttcat cttcttgaca tttaacccag tttgaatccc tttcaatttc tgctttttcc 
     3541 tccaaactat cgaccctcct gtttctgtcc aacttatgtc ctagttccaa ttcgatcgca 
     3601 ttaataactg cttcaaatgt tattgtgtca tcgttgactt taggtaattt ctccaaatgc 
     3661 ataatcaaac tatttaagga agatcggaat tcgtcgaaca cttcagtttc cgtaatgatc 
     3721 tgatcgtctt tatccacatg ttgtaattca ctaaaatcta aaacgtattt ttcaatgcat 
     3781 aaatcgttct ttttattaat aatgcagatg gaaaatctgt aaacgtgcgt taatttagaa 
     3841 agaacatcca gtataagttc ttctatatag tcaattaaag caggatgcct attaatggga 
     3901 acgaactgcg gcaagttgaa tgactggtaa gtagtgtagt cgaatgactg aggtgggtat 
     3961 acatttctat aaaataaaat caaattaatg tagcatttta agtataccct cagccacttc 
     4021 tctacccatc tattcataaa gctgacgcaa cgattactat tttttttttc ttcttggatc 
     4081 tcagtcgtcg caaaaacgta taccttcttt ttccgacctt ttttttagct ttctggaaaa 
     4141 gtttatatta gttaaacagg gtctagtctt agtgtgaaag ctagtggttt cgattgactg 
     4201 atattaagaa agtggaaatt aaattagtag tgtagacgta tatgcatatg tatttctcgc 
     4261 ctgtttatgt ttctacgtac ttttgattta tagcaagggg aaaagaaata catactattt 
     4321 tttggtaaag gtgaaagcat aatgtaaaag ctagaataaa atggacgaaa taaagagagg 
     4381 cttagttcat cttttttcca aaaagcaccc aatgataata actaaaatga aaaggatttg 
     4441 ccatctgtca gcaacatcag ttgtgtgagc aataataaaa tcatcacctc cgttgccttt 
     4501 agcgcgtttg tcgtttgtat cttccgtaat tttagtctta tcaatgggaa tcataaattt 
     4561 tccaatgaat tagcaatttc gtccaattct ttttgagctt cttcatattt gctttggaat 
     4621 tcttcgcact tcttttccca ttcatctctt tcttcttcca aagcaacgat ccttctaccc 
     4681 atttgctcag agttcaaatc ggcctctttc agtttatcca ttgcttcctt cagtttggct 
     4741 tcactgtctt ctagctgttg ttctagatcc tggtttttct tggtgtagtt ctcattatta 
     4801 gatctcaagt tattggagtc ttcagccaat tgctttgtat cagacaattg actctctaac 
     4861 ttctccactt cactgtcgag ttgctcgttt ttagcggaca aagatttaat ctcgttttct 
     4921 ttttcagtgt tagattgctc taattctttg agctgttctc tcagctcctc atatttttct 
     4981 tgccatgact cagattctaa ttttaagcta ttcaatttct ctttgatc 
// 
 
